At this year's RSNA show, Vidar will debut the Vision 3000 offering, designed to compete in price with computed radiography systems. Its target market niche includes imaging centers, orthopedic practices, small hospitals, and hospital outpatient areas.
Vision 3000 has received U.S. Food and Drug Administration (FDA) clearance and is available in the U.S. It is being phased in worldwide throughout 2007.
Vidar introduced the Vision 4000 DR system earlier in 2006 as a higher-end system for small- to medium-sized hospitals. It, too, has FDA clearance.
By Robert Bruce
AuntMinnie.com contributing writer
October 30, 2006
Copyright © 2006 AuntMinnie.com